Kymera Therapeutics (KYMR) PT Raised to $84 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $84.00 (from $70.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
